JPMorgan lifted Eli Lilly to $1,400 and AbbVie drew a string of target hikes as a new Medicare GLP-1 program widens access. Investorideas.com (www.investorideas.com newswire) a trusted platform for investing…
Tag:
obesity
-
-
Lilly says experimental obesity drug delivered weight loss across all stages of menopause
-
Smaller biotechs see new mechanisms of actions as future of obesity treatments
